Hokkaido University · Faculty of Medicine / Graduate School of Medicine / Medical Research Institute · 特任助教

Research keywordsCancer Stem Cells・Ovarian Cancer・Preeclampsia・医学・歯学・薬学・保健・Internal・medicine・Urine

This is a public-data preview. Personalized fit, contact angles, and saved workflows require sign-in.

• The significance of N6-methyladenosine-modified non-coding RNAs in different disorders2023 · European Journal of Pharmacology, 175644, 175644, Elsevier {BV}, 2023年03月,
• Integrated multi-omics analyses and functional validation reveal TTK as a novel EMT activator for endometrial cancer2023 · Journal of Translational Medicine, 21, 1, Springer Science and Business Media {LLC}, 2023年02月25日,
• Combination therapy with bevacizumab and a CCR2 inhibitor for human ovarian cancer: An in vivo validation study.2023 · Cancer medicine, 12, 8, 9697, 9708, 2023年02月22日,
• Germline PRDM1 Variant rs2185379 in Long-Term Recurrence-Free Survivors of Advanced Ovarian Cancer2022 · Pharmacogenomics and Personalized Medicine, 15, 977, 984, 2022年11月,

• 妊娠高血圧腎症：尿中Podocyte検出の 臨床的意義の解析
• Tリンパ球におけるPRDM1遺伝子多型と抗腫瘍免疫機能との相関に関する基礎的研究
• PRDM1 機能変化に伴う T リンパ球の抗腫瘍免疫能に関 する基礎的研究
• 卵巣がん培養細胞を用いたがん幹細胞形質誘導系の確立と治療標的の探索

• Official profile